Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 2/20 | 0.75 |
| ▸ | MC3R | P41968 | 2/20 | 0.75 |
| ▸ | MC1R | Q01726 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | HTR2A | P28223 | 5/20 | 0.55 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 3/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5947571 | 0.91 | KMT2A (0.79) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5947833 | 0.89 | HTR2A (0.74) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5947854 | 0.88 | KMT2A (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL23745489 | 0.88 | KMT2A (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5948017 | 0.88 | KMT2A (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| Hydrochloric Acid SCHEMBL23722135 | 0.87 | KMT2A (0.70) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5947705 | 0.87 | KMT2A (0.72) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL7866517 | 0.86 | MC5R (1.00) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5947375 | 0.86 | KMT2A (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL5947524 | 0.85 | KMT2A (0.70) | MC5RMC3RMC1RKMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060009511-A9 | N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor | CHEN ZHAOGEN | 2006-01-12 | — | — | US | claimed |
| CN-1610547-A | N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor | LILLY CO ELI (US) | 2005-04-27 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009511-A9 | N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor | HTR6, HTR2C, HTR1B | MC5R 50/4885MC3R 86/4885MC1R 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.